Federal Supply Schedule 36F79722D0205
Award Date
9/15/22
Last Date to Order
9/14/27
Federal Agency
Veterans Integrated Service Network 12
Awardee
Specgx LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The contract, valued at $5,892,883.55, was awarded on September 27, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of September 26, 2029. Under this IDC, Specgx primarily provides the Department of Veterans Affairs (VA), Department of Defense, Bureau of...
The federal contract IDV awarded to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, is a single-award Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,154,058.30 over five years, establishes Specgx LLC as the national supply source for Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) 36E79721D0013 to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, with a ceiling value of $28,220,287.65. The contract is for the supply of Buprenorphine HCL/Naloxone HCL Sublingual Tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The period of performance is from June 7, 2021 to June 6, 2022, with four one-year option periods....
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a ceiling value of $6,939,222.50, awarded on July 15, 2019 to the prime contractor Specgx LLC, doing business as Mallinckrodt Pharmaceuticals. The contract was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, to establish a national supply source for pharmaceutical products used by the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned, for-profit pharmaceutical manufacturer. The $7.3 million contract is for the supply of oxycodone HCL-acetaminophen tablets in various strengths and package sizes to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The...
The key products and services being delivered under this Federal Supply Schedule (FSS) contract IDV award include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Mallinckrodt Hospital Products Inc., is a foreign-owned, for-profit entity registered to receive federal government awards. This $140,039,590 multiple award FSS contract was issued by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a $1.388 million single-award Indefinite Delivery Contract (IDC) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, for the supply of Atropine Sulfate/Diphenoxylate Hydrochloride tablets. The contract has a base period of one year from May 27, 2023 to May 26, 2024, with four one-year option periods, for a total potential performance period of 5 years. This IDC allows the VA, Department of Defense, Bureau...
Mallinckrodt ARD LLC holds a prime contract under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), awarded a value of $27,963,350 in March 2020 with a period of performance through March 2026. The contract enables federal agencies such as the Department of Health and Human Services' National Institutes of Health (NIH) and the Department of Veterans Affairs (VA) to procure a range of pharmaceutical products and related services through issued...
This Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) awarded to Indivior Inc., a pharmaceutical manufacturer, provides a $131.9 million ceiling for the procurement of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) allows the VA to order a broad range of medical supplies, including Indivior's Sublocade medication for opioid use disorder treatment. The contract has...
The Federal Supply Schedule contract awarded to Marlex Pharmaceuticals Inc. (DUNS: VSSNJEFMPLB3) by the Department of Veterans Affairs (VA) is a $88,000,000 multiple-award contract for the supply of pharmaceutical and hematology-related products under Schedule 65 IB. The contract, which runs from February 1, 2025 to February 1, 2030, covers a wide range of generic medications, including but not limited to haloperidol, prednisone, methocarbamol, loratadine, cetirizine, clonidine, gabapentin,...